國立虎尾科技大學 |

Assessment of Preclinical Organ Damage in Hypertension

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Assessment of Preclinical Organ Damage in Hypertension/ edited by Enrico Agabiti Rosei, Giuseppe Mancia.
其他作者:	Agabiti Rosei, Enrico.
面頁冊數:	VIII, 218 p. 44 illus., 28 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cardiology. -
電子資源:	https://doi.org/10.1007/978-3-319-15603-3
ISBN:	9783319156033

Assessment of Preclinical Organ Damage in Hypertension
Assessment of Preclinical Organ Damage in Hypertension[electronic resource] /edited by Enrico Agabiti Rosei, Giuseppe Mancia. - 1st ed. 2015. - VIII, 218 p. 44 illus., 28 illus. in color.online resource.

PART I: HEART 1 Electrocardiography -- 2 Echocardiography -- 3 New techniques: 3D, CT, MRI -- PART II: LARGE ARTERIES 4 Ultrasound of Carotid IMT and plaque.- 5 Ultrasound of the Aorta/coronary arteries.- 6 Pulse wave velocity and central BP.- 7 Ankle-brachial index -- 8 Atherosclerosis and general principles of arterial imaging -- 9 Imaging and ageing of the aorta and large arteries in the lower extremities -- PART III: SMALL ARTERIES 10 Micro myography -- 11 Damage of the retinal arterioles -- 12 Capillaroscopy -- 13 Other techniques for assessment -- PART IV: KIDNEY 14 Proteinuria -- 15 Glomerular Filtration Rate -- 16 Other techniques -- PART V: BRAIN 17 RMN/TC: Evaluation of Brain damage -- 18 Questionnaires for cognitive function -- 19 Other techniques for neurological damage.- 20 Relation between blood pressure and markers of organ damage.

This book presents up-to-date information on how to assess early preclinical alterations in the heart, the small and large arteries and the kidney in the general and the hypertensive population, using the most sensitive, specific and cost-effective techniques. A wide variety of techniques are discussed, with careful attention to the latest developments. For each organ, evidence is documented regarding the prevalence of organ damage. Information is provided on the potential induction of regression of organ damage by treatment, the criteria for establishing significant changes and the clinical prognostic significance of regression. The manual will be invaluable for all practitioners responsible for the clinical management of hypertensive patients, given that the assessment of early preclinical cardiovascular and renal damage permits more accurate risk stratification at baseline and facilitates evaluation of cardiovascular protection when regression of structural changes is achieved during treatment.

ISBN: 9783319156033

Standard No.: 10.1007/978-3-319-15603-3doiSubjects--Topical Terms:

593957
Cardiology.

LC Class. No.: RC681-688.2

Dewey Class. No.: 616.12

Assessment of Preclinical Organ Damage in Hypertension
LDR:03234nam a22003975i 4500 001 966483
003 DE-He213
005 20200630153008.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319156033 $9 978-3-319-15603-3
024 7 $a 10.1007/978-3-319-15603-3 $2 doi
035 $a 978-3-319-15603-3
050 4 $a RC681-688.2
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 616.12 $2 23
245 1 0 $a Assessment of Preclinical Organ Damage in Hypertension $h [electronic resource] / $c edited by Enrico Agabiti Rosei, Giuseppe Mancia.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a VIII, 218 p. 44 illus., 28 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a PART I: HEART 1 Electrocardiography -- 2 Echocardiography -- 3 New techniques: 3D, CT, MRI -- PART II: LARGE ARTERIES 4 Ultrasound of Carotid IMT and plaque.- 5 Ultrasound of the Aorta/coronary arteries.- 6 Pulse wave velocity and central BP.- 7 Ankle-brachial index -- 8 Atherosclerosis and general principles of arterial imaging -- 9 Imaging and ageing of the aorta and large arteries in the lower extremities -- PART III: SMALL ARTERIES 10 Micro myography -- 11 Damage of the retinal arterioles -- 12 Capillaroscopy -- 13 Other techniques for assessment -- PART IV: KIDNEY 14 Proteinuria -- 15 Glomerular Filtration Rate -- 16 Other techniques -- PART V: BRAIN 17 RMN/TC: Evaluation of Brain damage -- 18 Questionnaires for cognitive function -- 19 Other techniques for neurological damage.- 20 Relation between blood pressure and markers of organ damage.
520 $a This book presents up-to-date information on how to assess early preclinical alterations in the heart, the small and large arteries and the kidney in the general and the hypertensive population, using the most sensitive, specific and cost-effective techniques. A wide variety of techniques are discussed, with careful attention to the latest developments. For each organ, evidence is documented regarding the prevalence of organ damage. Information is provided on the potential induction of regression of organ damage by treatment, the criteria for establishing significant changes and the clinical prognostic significance of regression. The manual will be invaluable for all practitioners responsible for the clinical management of hypertensive patients, given that the assessment of early preclinical cardiovascular and renal damage permits more accurate risk stratification at baseline and facilitates evaluation of cardiovascular protection when regression of structural changes is achieved during treatment.
650 0 $a Cardiology. $3 593957
650 0 $a Angiology. $3 668966
650 0 $a Nephrology. $3 668354
650 0 $a Health promotion. $3 565089
650 2 4 $a Health Promotion and Disease Prevention. $3 593964
700 1 $a Agabiti Rosei, Enrico. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1262094
700 1 $a Mancia, Giuseppe. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 777973
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319156026
776 0 8 $i Printed edition: $z 9783319156040
776 0 8 $i Printed edition: $z 9783319358925
856 4 0 $u https://doi.org/10.1007/978-3-319-15603-3
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)